EUVIMEDEUVIMED entdecken
Crossref

Test-Negative Study Designs for Evaluating Vaccine Effectiveness

Natalie Dean, Avnika B Amin

JAMA · 09.07.2024 · 332 (2) · 163

DOI: 10.1001/jama.2024.5633 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, erschienen am 09.07.2024. Verfasst von Natalie Dean und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia. Hauptthemen laut MEDLINE: Research Design, Vaccine Efficacy. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 9 Literaturangaben. Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This JAMA Guide to Statistics and Methods article explains the test-negative study design, an observational study design routinely used to estimate vaccine effectiveness, and examines its use in a study that estimated the performance of messenger RNA boosters against the Omicron variant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Research DesignVaccine EfficacyHumansCOVID-19 Vaccines

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia.

Förderung

  • NIAID NIH HHS

Zitieren

APA

Dean, N., & Amin, A. B. (2024). Test-Negative Study Designs for Evaluating Vaccine Effectiveness. JAMA, 332(2), 163. https://doi.org/10.1001/jama.2024.5633

Vancouver

Dean N, Amin AB. Test-Negative Study Designs for Evaluating Vaccine Effectiveness. JAMA. 2024;332(2):163. doi:10.1001/jama.2024.5633

BibTeX
@article{Dean2024,
  author = {Dean, Natalie and Amin, Avnika B},
  title = {Test-Negative Study Designs for Evaluating Vaccine Effectiveness},
  journal = {JAMA},
  year = {2024},
  volume = {332},
  number = {2},
  pages = {163},
  doi = {10.1001/jama.2024.5633}
}
Kostenlos starten →